Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Alzheimer's Disease

Free Subscription Articles published in Neurobiol Dis Retrieve available abstracts of 148 articles: HTML format

Single Articles

May 2026
1. OLMSTED ZT, Sofroniew MV
   APP as an innate injury-response molecule.
   Neurobiol Dis. 2026;222:107361.
   PubMed     Abstract available
   
   
   
2. CARROLL T, Pfendler D, Alhaj Arhayem H, Thoma R, et al
   Tunable tau expression in C. elegans neurons reveals that early-AD tau phosphorylation selectively impacts behavior and mitochondrial quality control.
   Neurobiol Dis. 2026;222:107350.
   PubMed     Abstract available
   
   
   April 2026
3. WU F, Fan J, Yang Z, Huang M, et al
   alpha1A-adrenergic receptor activation ameliorates fragmented spatial exploration by improving astrocyte-neuronal coupling in the medial entorhinal cortex of Alzheimer's disease mice.
   Neurobiol Dis. 2026 Apr 15:107398. doi: 10.1016/j.nbd.2026.107398.
   PubMed     Abstract available
   
   
   
4. BALASUBRAMANIAN N, Gaudencio G, Khan KM, Biggerstaff N, et al
   Adolescent social isolation facilitates tau spread in raphe nuclei, linking depression and hyperalgesia in Alzheimer's disease.
   Neurobiol Dis. 2026;224:107393.
   PubMed     Abstract available
   
   
   March 2026
5. SIMPSON D, Morrone CD, Wear D, Khani A, et al
   Neurovascular large artery dilatation increases the risk for Alzheimer's disease pathology.
   Neurobiol Dis. 2026 Mar 27:107368. doi: 10.1016/j.nbd.2026.107368.
   PubMed     Abstract available
   
   
   
6. HUANG J, Rehman H, Doan C, Stein TD, et al
   Corrigendum to 'Circulating C-reactive protein influences polygenic risk of inflammatory genes expressed in brain endothelia for Alzheimer's disease' Neurobiology of Disease 219 (2026) Article Number 107257.
   Neurobiol Dis. 2026 Mar 16:107348. doi: 10.1016/j.nbd.2026.107348.
   PubMed    
   
   
   
7. GIUFFRE GM, Scalese A, Quaranta D, Donnarumma F, et al
   The impact of insulin resistance on cognitive impairment and cerebrospinal fluid biomarkers in Alzheimer's disease.
   Neurobiol Dis. 2026;222:107352.
   PubMed     Abstract available
   
   
   
8. JIANG Z, Saleem K, Fisher E, Li L, et al
   SGK1 inhibition restores excitability of cortical neurons derived from Alzheimer's disease patients.
   Neurobiol Dis. 2026;221:107345.
   PubMed     Abstract available
   
   
   February 2026
9. CHENG B, Cheng S, Wei W, Pan C, et al
   Residential green space, natural environment, domestic garden, and the risk of Parkinson's disease: A prospective cohort study.
   Neurobiol Dis. 2026 Feb 25:107334. doi: 10.1016/j.nbd.2026.107334.
   PubMed     Abstract available
   
   
   
10. RYSKAMP D, Wu L, Wu J, Kim D, et al
    Corrigendum to 'Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor' [Neurobiology of Disease Volume 124 April 2019 Pages 489-504].
    Neurobiol Dis. 2026 Feb 13:107311. doi: 10.1016/j.nbd.2026.107311.
    PubMed    
    
    
    January 2026
11. LANZILLOTTA S, Boccardi V, Zulli B, Napoli A, et al
    GDF-11, GDF-15, Jag-1, and leptin in neuronal-derived extracellular vesicles as aging-related biomarkers to identify individuals at risk of Alzheimer's dementia: A pilot study.
    Neurobiol Dis. 2026;220:107291.
    PubMed     Abstract available
    
    
    
12. HUANG J, Rehman H, Doan C, Stein TD, et al
    Circulating C-reactive protein influences polygenic risk of inflammatory genes expressed in brain endothelia for Alzheimer's disease.
    Neurobiol Dis. 2026 Jan 13:107257. doi: 10.1016/j.nbd.2026.107257.
    PubMed     Abstract available
    
    
    
13. NAGARAJAN V, Libowitz CL, Ackley BD, Wolfe MS, et al
    A C. elegans model of familial Alzheimer's disease shows age-dependent synaptic degeneration independent of amyloid beta-peptide.
    Neurobiol Dis. 2026;219:107267.
    PubMed     Abstract available
    
    
    
14. ISHIKAWA R, Yamazaki Y, Nakazawa N, Li X, et al
    A novel conditional knock-in mouse model for APOE4-to-APOE3 switching.
    Neurobiol Dis. 2026;218:107244.
    PubMed     Abstract available
    
    
    December 2025
15. BELLOMO G, Toja A, Gaetani L, Nardi G, et al
    Cerebrospinal fluid alpha-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease.
    Neurobiol Dis. 2025 Dec 22:107234. doi: 10.1016/j.nbd.2025.107234.
    PubMed     Abstract available
    
    
    November 2025
16. RAFIEE Z, Poceviciute D, Santiago J, Mahmoud R, et al
    CSF pTDP-43 across the Alzheimer's spectrum: Links to amyloid, APOE and vasculopathy.
    Neurobiol Dis. 2025;217:107193.
    PubMed     Abstract available
    
    
    
17. AUNG KZ, Zin SS, Wu X, Myint ZW, et al
    Disentangling the inverse relationship between cancer and Alzheimer's or Parkinson's disease: A systematic review on Mendelian randomization studies.
    Neurobiol Dis. 2025;217:107190.
    PubMed     Abstract available
    
    
    
18. YANG S, Xie B, Liao D, Sun Y, et al
    Trajectory of olfactory cortex degeneration from normal cognition to Alzheimer's disease: Insights from multimodal neuroimaging.
    Neurobiol Dis. 2025;217:107181.
    PubMed     Abstract available
    
    
    
19. ATTALI RS, Farfara D, Cooper I, Levin A, et al
    Corrigendum to "Naphthoquinone-tyrptophan reduces neurotoxic Abeta*56 levels and improves cognition in Alzheimer's disease animal model" Neurobiol Dis. 46(3) (2012):663-72.
    Neurobiol Dis. 2025 Nov 7:107170. doi: 10.1016/j.nbd.2025.107170.
    PubMed    
    
    
    
20. SCHMEETZ J, van de Sande N, Ramakers IHGB, Verhey FRJ, et al
    Enrichment of phosphorylated Tau 181 levels in tear fluid-derived extracellular vesicles.
    Neurobiol Dis. 2025;216:107134.
    PubMed     Abstract available
    
    
    
21. XU G, Angelle C, Huilgol D, Sacilotto P, et al
    Comparison of the ApoE allelic variants in the formation of intracerebral Abeta deposits.
    Neurobiol Dis. 2025;216:107105.
    PubMed     Abstract available
    
    
    
22. MA C, Campbell K, Kovalenko A, Li J, et al
    Nutrient sensing receptor GPRC6A regulates mTORC1 signaling and Tau biology.
    Neurobiol Dis. 2025;216:107054.
    PubMed     Abstract available
    
    
    October 2025
23. ANDRAINI T, Faure LM, Mouledous L, Gauzin S, et al
    Targeting adult-born neurons to correct early deficits in pattern separation in the Tg2576 mouse model of Alzheimer's disease.
    Neurobiol Dis. 2025;217:107158.
    PubMed     Abstract available
    
    
    
24. WEI J, Xiao T, Lyu J, Zhao Y, et al
    Mitophagy in Alzheimer's disease and its potential as a therapeutic target.
    Neurobiol Dis. 2025 Oct 28:107162. doi: 10.1016/j.nbd.2025.107162.
    PubMed     Abstract available
    
    
    
25. LIU A, Do Carmo S, Antel JP, Kuhlmann T, et al
    White matter degeneration precedes tau aggregation in rats with Alzheimer's-like tauopathy.
    Neurobiol Dis. 2025;216:107149.
    PubMed     Abstract available
    
    
    
26. YE Q, Gast G, Holmes TC, Xu X, et al
    Hippocampal neural circuit mechanisms in Alzheimer's disease revealed by viral-genetic circuits mapping.
    Neurobiol Dis. 2025 Oct 11:107139. doi: 10.1016/j.nbd.2025.107139.
    PubMed     Abstract available
    
    
    
27. WANG Y, Lin J, Qu Y, Ding Y, et al
    Biomarker profile of a Chinese ALS cohort: A comprehensive clinical-biomarkers-imaging analysis.
    Neurobiol Dis. 2025;214:107059.
    PubMed     Abstract available
    
    
    
28. NEU M, Parfentev I, Potts GK, Stoberl N, et al
    A role for the autophagy receptor NBR1 in the degradation of tau aggregates.
    Neurobiol Dis. 2025;214:107060.
    PubMed     Abstract available
    
    
    
29. GIANNELLI S, Eroli F, Loera-Valencia R, Leoni V, et al
    Elevated 24-hydroxycholesterol levels counteract okadaic acid-induced tau hyperphosphorylation and neuronal morphology impairment.
    Neurobiol Dis. 2025;214:107029.
    PubMed     Abstract available
    
    
    September 2025
30. YU Y, Zhou RZ, Nilsson P, Winblad B, et al
    Altered APP trafficking drives amyloidogenic processing in primary neurons from the App(NL-F) knock-in mouse model of Alzheimer's disease.
    Neurobiol Dis. 2025 Sep 28:107129. doi: 10.1016/j.nbd.2025.107129.
    PubMed     Abstract available
    
    
    
31. OLAYINKA OA, O'Neill N, Empawi JA, Bock P, et al
    Single nucleus RNA sequencing unveils relationship between microglia and endothelial cells in mixed Alzheimer's disease and vascular pathology.
    Neurobiol Dis. 2025 Sep 27:107128. doi: 10.1016/j.nbd.2025.107128.
    PubMed     Abstract available
    
    
    
32. HEAVENER KS, Tamucci KA, Lee AJ, Kabra K, et al
    P2RX7 modulates the function of human microglia-like cells and mediates the association of IL18 with Alzheimer's disease traits.
    Neurobiol Dis. 2025 Sep 21:107106. doi: 10.1016/j.nbd.2025.107106.
    PubMed     Abstract available
    
    
    
33. STRINGER CA, Miyasato HKS, Camey KA, Ghadia KA, et al
    Regional differences in astrocytic Aquaporin-4 protein levels and distribution in aging and Alzheimer's disease in down syndrome.
    Neurobiol Dis. 2025 Sep 21:107114. doi: 10.1016/j.nbd.2025.107114.
    PubMed     Abstract available
    
    
    
34. ANTEQUERA D, Vargas T, Ugalde C, Spuch C, et al
    Retraction notice to "Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease" [Neurobiology of Disease 36 (2009) 42-50].
    Neurobiol Dis. 2025 Sep 11:107088. doi: 10.1016/j.nbd.2025.107088.
    PubMed    
    
    
    
35. ONO K, Noguchi M, Matsumoto Y, Yanase D, et al
    Retraction Notice to "Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro" [Neurobiology of Disease 20 (2005) 233-240].
    Neurobiol Dis. 2025 Sep 11:107087. doi: 10.1016/j.nbd.2025.107087.
    PubMed    
    
    
    
36. KRICK KE, Weekman EM, Johnson SN, Sudduth TL, et al
    Age-related cerebral amyloid angiopathy accumulation in the APPSw mouse model is associated with perivascular inflammation and brain-wide vascular and inflammatory gene and protein changes.
    Neurobiol Dis. 2025;213:107013.
    PubMed     Abstract available
    
    
    August 2025
37. CHEN Z, Bi S, He HL, Qi Z, et al
    Multimodal imaging of glymphatic dysfunction and retinal vascular changes as biomarkers for Alzheimer's disease.
    Neurobiol Dis. 2025 Aug 25:107064. doi: 10.1016/j.nbd.2025.107064.
    PubMed     Abstract available
    
    
    
38. SANTIAGO J, Poceviciute D, Vogel J, Brinkmalm G, et al
    Retinal tau phosphorylation in Alzheimer's disease: A mass spectrometry study.
    Neurobiol Dis. 2025;215:107057.
    PubMed     Abstract available
    
    
    
39. FRIDAY CM, Stephens IO, Smith CT, Lee S, et al
    APOE4 reshapes the lipid droplet proteome and modulates microglial inflammatory responses.
    Neurobiol Dis. 2025;212:106983.
    PubMed     Abstract available
    
    
    July 2025
40. SPENCER B, Schueler A, Sung D, Rissman RA, et al
    Differential roles of human tau isoforms in the modulation of inflammation and development of neuropathology.
    Neurobiol Dis. 2025;211:106942.
    PubMed     Abstract available
    
    
    
41. ZARE MS, Abedpoor N, Hajibabaie F, Walker AK, et al
    Gene co-expression patterns shared between chemobrain and neurodegenerative disease models in rodents.
    Neurobiol Dis. 2025;211:106944.
    PubMed     Abstract available
    
    
    
42. PELAGOTTI V, Plantone D, D'Amico F, Raffa S, et al
    [(18)F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's disease.
    Neurobiol Dis. 2025 Jul 1:107014. doi: 10.1016/j.nbd.2025.107014.
    PubMed     Abstract available
    
    
    June 2025
43. CHEN KS, Noureldein MH, Rigan DM, Hayes JM, et al
    Interneuron transcriptomics reveals pathologic markers of Alzheimer's disease progression.
    Neurobiol Dis. 2025 Jun 25:107012. doi: 10.1016/j.nbd.2025.107012.
    PubMed     Abstract available
    
    
    
44. MORAIS RF, Sousa JM, Koba C, Andres L, et al
    Differential involvement of neurotransmitter pathways in AD, bvFTD and MCI: Whole-brain MRI analysis.
    Neurobiol Dis. 2025;209:106897.
    PubMed     Abstract available
    
    
    May 2025
45. SORIANO-HERRADOR C, Ubeda-Banon I, Villanueva-Anguita P, Saiz-Sanchez D, et al
    The chaperones HSP90AA1, HSP90AB1 and BAG3 are specifically distributed among human hippocampal subfields during different Alzheimer's disease stages.
    Neurobiol Dis. 2025 May 26:106971. doi: 10.1016/j.nbd.2025.106971.
    PubMed     Abstract available
    
    
    
46. BADINA AM, Ceyzeriat K, Amosse Q, Tresh A, et al
    Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease.
    Neurobiol Dis. 2025;211:106950.
    PubMed     Abstract available
    
    
    
47. CERNOTOVA D, Hruzova K, Tous J, Janca R, et al
    Early social deficits in TgF344-AD rats are accompanied by sex-specific parvalbumin-positive interneuron reduction and altered brain oscillations in the hippocampal CA2.
    Neurobiol Dis. 2025;208:106875.
    PubMed     Abstract available
    
    
    April 2025
48. VAN KRUINING D, Losen M, Dehairs J, Swinnen JV, et al
    Early plasma ceramide and sphingomyelin levels reflect APOE genotype but not familial Alzheimer's disease gene mutations in female 5xFAD mice, with brain-region specific sphingolipid alterations.
    Neurobiol Dis. 2025 Apr 17:106923. doi: 10.1016/j.nbd.2025.106923.
    PubMed     Abstract available
    
    
    
49. JOHNSON CN, Evans MR, Blankenship AE, John CS, et al
    Human skeletal muscle mitochondrial pathways are impacted by a neuropathologic diagnosis of Alzheimer's disease.
    Neurobiol Dis. 2025 Apr 16:106916. doi: 10.1016/j.nbd.2025.106916.
    PubMed     Abstract available
    
    
    
50. SHI J, Zhang M, Hu Y, Liu J, et al
    Differences in transcriptome characteristics and drug repositioning of Alzheimer's disease according to sex.
    Neurobiol Dis. 2025;210:106909.
    PubMed     Abstract available
    
    
    March 2025
51. FATIMA G, Ashiquzzaman A, Kim SS, Kim YR, et al
    Vascular and glymphatic dysfunction as drivers of cognitive impairment in Alzheimer's disease: Insights from computational approaches.
    Neurobiol Dis. 2025 Mar 17:106877. doi: 10.1016/j.nbd.2025.106877.
    PubMed     Abstract available
    
    
    
52. TAKEUCHI LE, Kalia LV, Simmons CA
    Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier.
    Neurobiol Dis. 2025;208:106864.
    PubMed     Abstract available
    
    
    
53. PINI L, Brusini L, Griffa A, Cruciani F, et al
    Functional dynamic network connectivity differentiates biological patterns in the Alzheimer's disease continuum.
    Neurobiol Dis. 2025 Mar 11:106866. doi: 10.1016/j.nbd.2025.106866.
    PubMed     Abstract available
    
    
    
54. WAN L, Zhong P, Li P, Ren Y, et al
    CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model.
    Neurobiol Dis. 2025;206:106826.
    PubMed     Abstract available
    
    
    February 2025
55. VOLLHARDT A, Frolich L, Stockbauer AC, Danek A, et al
    Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia.
    Neurobiol Dis. 2025 Feb 23:106845. doi: 10.1016/j.nbd.2025.106845.
    PubMed     Abstract available
    
    
    
56. SUN YR, Lv QK, Liu JY, Wang F, et al
    New perspectives on the glymphatic system and the relationship between glymphatic system and neurodegenerative diseases.
    Neurobiol Dis. 2025;205:106791.
    PubMed     Abstract available
    
    
    
57. NAKANO H, Hikishima S, Mori M, Minamikawa J, et al
    Globular-shaped Abeta oligomers have diverse mechanisms for promoting Abeta aggregations with the facilitation of fibril elongation.
    Neurobiol Dis. 2025;205:106775.
    PubMed     Abstract available
    
    
    January 2025
58. MA X, Prokopenko D, Wang N, Aikawa T, et al
    Alzheimer's disease risk ABCA7 p.A696S variant disturbs the microglial response to amyloid pathology in mice.
    Neurobiol Dis. 2025;206:106813.
    PubMed     Abstract available
    
    
    
59. FAURE LMP, Gauzin S, Lejards C, Rampon C, et al
    Fine social discrimination of siblings in mice: Implications for early detection of Alzheimer's disease.
    Neurobiol Dis. 2025 Jan 13:106799. doi: 10.1016/j.nbd.2025.106799.
    PubMed     Abstract available
    
    
    
60. WANG W, Myers SJ, Ollen-Bittle N, Whitehead SN, et al
    Elevation of ganglioside degradation pathway drives GM2 and GM3 within amyloid plaques in a transgenic mouse model of Alzheimer's disease.
    Neurobiol Dis. 2025 Jan 8:106798. doi: 10.1016/j.nbd.2025.106798.
    PubMed     Abstract available
    
    
    
61. ESCARCEGA RD, M J VK, Kyriakopoulos VE, Ortiz GJ, et al
    Serum metabolome profiling in patients with mild cognitive impairment reveals sex differences in lipid metabolism.
    Neurobiol Dis. 2025;204:106747.
    PubMed     Abstract available
    
    
    November 2024
62. JAHOLKOWSKI P, Bahrami S, Fominykh V, Hindley GFL, et al
    Charting the shared genetic architecture of Alzheimer's disease, cognition, and educational attainment, and associations with brain development.
    Neurobiol Dis. 2024 Nov 26:106750. doi: 10.1016/j.nbd.2024.106750.
    PubMed     Abstract available
    
    
    
63. LIU H, Tan AYS, Mehrabi NF, Turner CP, et al
    Astrocytic proteins involved in regulation of the extracellular environment are increased in the Alzheimer's disease middle temporal gyrus.
    Neurobiol Dis. 2024 Nov 25:106749. doi: 10.1016/j.nbd.2024.106749.
    PubMed     Abstract available
    
    
    
64. LI N, Wang X, Lin R, Yang F, et al
    ANGPTL4-mediated microglial lipid droplet accumulation: Bridging Alzheimer's disease and obesity.
    Neurobiol Dis. 2024 Nov 20:106741. doi: 10.1016/j.nbd.2024.106741.
    PubMed     Abstract available
    
    
    October 2024
65. MARTINEZ-GARDEAZABAL J, Pereira-Castelo G, Moreno-Rodriguez M, Llorente-Ovejero A, et al
    Sphingosine 1-phosphate receptor subtype 1 (S1P(1)) activity in the course of Alzheimer's disease.
    Neurobiol Dis. 2024 Oct 22:106713. doi: 10.1016/j.nbd.2024.106713.
    PubMed     Abstract available
    
    
    
66. TANIGUCHI D, Shimonaka S, Imtiaz A, Elahi M, et al
    Legumain/asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment.
    Neurobiol Dis. 2024;201:106686.
    PubMed     Abstract available
    
    
    
67. YAMAGUCHI T, Hamano T, Sada K, Asano R, et al
    Syk inhibitors reduce tau protein phosphorylation and oligomerization.
    Neurobiol Dis. 2024;201:106656.
    PubMed     Abstract available
    
    
    
68. SEKIYA M, Sakakibara Y, Hirota Y, Ito N, et al
    Decreased plasma nicotinamide and altered NAD(+) metabolism in glial cells surrounding Abeta plaques in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024 Oct 5:106694. doi: 10.1016/j.nbd.2024.106694.
    PubMed     Abstract available
    
    
    
69. MARMOLEJO-GARZA A, Chatre L, Croteau DL, Herron-Bedoya A, et al
    Nicotinamide riboside modulates the reactive species interactome, bioenergetic status and proteomic landscape in a brain-region-specific manner.
    Neurobiol Dis. 2024;200:106645.
    PubMed     Abstract available
    
    
    September 2024
70. MAGALHAES R, Marques F, Selingue E, Boumezbeur F, et al
    A longitudinal MRI analysis reveals altered brain connectivity and microstructural changes in a transgenic mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024 Sep 23:106679. doi: 10.1016/j.nbd.2024.106679.
    PubMed     Abstract available
    
    
    
71. CROCKETT RA, Casselton C, Howard TM, Wilkins KB, et al
    Lateral thinking: Neurodegeneration of the cortical cholinergic system in Alzheimer's disease.
    Neurobiol Dis. 2024;201:106677.
    PubMed     Abstract available
    
    
    
72. ZHUO L, Pang K, Dai J, Wu B, et al
    The neurophysiological mechanisms of medial prefrontal-perirhinal cortex circuit mediating temporal order memory decline in early stage of AD rats.
    Neurobiol Dis. 2024;199:106584.
    PubMed     Abstract available
    
    
    August 2024
73. DOUCETTE L, Turnbill V, Carlin K, Cavanagh A, et al
    Neocortical cholinergic pathology after neonatal brain injury is increased by Alzheimer's disease-related genes in mice.
    Neurobiol Dis. 2024 Aug 5:106629. doi: 10.1016/j.nbd.2024.106629.
    PubMed     Abstract available
    
    
    
74. CEYZERIAT K, Badina AM, Petrelli F, Montessuit S, et al
    Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024;200:106623.
    PubMed     Abstract available
    
    
    July 2024
75. LOPEZ-CERDAN A, Andreu Z, Hidalgo MR, Soler-Saez I, et al
    An integrated approach to identifying sex-specific genes, transcription factors, and pathways relevant to Alzheimer's disease.
    Neurobiol Dis. 2024;199:106605.
    PubMed     Abstract available
    
    
    
76. BUCHANAN RA, Wang Y, May JM, Harrison FE, et al
    Ascorbate insufficiency disrupts glutamatergic signaling and alters electroencephalogram phenotypes in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024 Jul 12:106602. doi: 10.1016/j.nbd.2024.106602.
    PubMed     Abstract available
    
    
    June 2024
77. LIZAMA BN, North HA, Pandey K, Williams C, et al
    An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease.
    Neurobiol Dis. 2024 Jun 22:106575. doi: 10.1016/j.nbd.2024.106575.
    PubMed     Abstract available
    
    
    
78. CHANDRASHEKAR DV, Roules GC, Jagadeesan N, Panchal UR, et al
    Hepatic LRP-1 plays an important role in amyloidosis in Alzheimer's disease mice: Potential role in chronic heavy alcohol feeding.
    Neurobiol Dis. 2024 Jun 15:106570. doi: 10.1016/j.nbd.2024.106570.
    PubMed     Abstract available
    
    
    May 2024
79. PAIVA I, Seguin J, Grgurina I, Singh AK, et al
    Dysregulated expression of cholesterol biosynthetic genes in Alzheimer's disease alters epigenomic signatures of hippocampal neurons.
    Neurobiol Dis. 2024 May 22:106538. doi: 10.1016/j.nbd.2024.106538.
    PubMed     Abstract available
    
    
    
80. CANET G, Gratuze M, Zussy C, Bouali ML, et al
    Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice.
    Neurobiol Dis. 2024 May 9:106526. doi: 10.1016/j.nbd.2024.106526.
    PubMed     Abstract available
    
    
    
81. XIE B, Yang S, Hao Y, Sun Y, et al
    Impaired olfactory identification in dementia-free individuals is associated with the functional abnormality of the precuneus.
    Neurobiol Dis. 2024;194:106483.
    PubMed     Abstract available
    
    
    April 2024
82. RODRIGUES MES, Bolen ML, Blackmer-Raynolds L, Schwartz N, et al
    Diet-induced metabolic and immune impairments are sex-specifically modulated by soluble TNF signaling in the 5xFAD mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024 Apr 24:106511. doi: 10.1016/j.nbd.2024.106511.
    PubMed     Abstract available
    
    
    
83. LEMCHE E, Killick R, Mitchell J, Caton PW, et al
    Molecular mechanisms linking type 2 diabetes mellitus and late-onset Alzheimer's disease: A systematic review and qualitative meta-analysis.
    Neurobiol Dis. 2024;196:106485.
    PubMed     Abstract available
    
    
    
84. TONG B, Ba Y, Li Z, Yang C, et al
    Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.
    Neurobiol Dis. 2024 Apr 18:106505. doi: 10.1016/j.nbd.2024.106505.
    PubMed     Abstract available
    
    
    
85. SCHRAEN-MASCHKE S, Duhamel A, Vidal JS, Ramdane N, et al
    The free plasma amyloid Abeta(1)(-)(42)/Abeta(1)(-)(40) ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Abeta(1)(-)(42)/Abeta(1)(-)(40) ratio. The BALTAZAR study.
    Neurobiol Dis. 2024;193:106459.
    PubMed     Abstract available
    
    
    
86. JIAO LL, Dong HL, Liu MM, Wu PL, et al
    The potential roles of salivary biomarkers in neurodegenerative diseases.
    Neurobiol Dis. 2024;193:106442.
    PubMed     Abstract available
    
    
    
87. JADHAV VS, Stair JG, Eck RJ, Smukowski SN, et al
    Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets.
    Neurobiol Dis. 2024;193:106441.
    PubMed     Abstract available
    
    
    March 2024
88. BONIFAZI G, Luchena C, Gaminde-Blasco A, Ortiz-Sanz C, et al
    A nonlinear meccano for Alzheimer's emergence by amyloid beta-mediated glutamatergic hyperactivity.
    Neurobiol Dis. 2024 Mar 15:106473. doi: 10.1016/j.nbd.2024.106473.
    PubMed     Abstract available
    
    
    
89. YAMASHIRO K, Takabayashi K, Kamagata K, Nishimoto Y, et al
    Free water in gray matter linked to gut microbiota changes with decreased butyrate producers in Alzheimer's disease and mild cognitive impairment.
    Neurobiol Dis. 2024 Mar 5:106464. doi: 10.1016/j.nbd.2024.106464.
    PubMed     Abstract available
    
    
    
90. ZENG J, Liao Z, Yang H, Wang Q, et al
    T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease.
    Neurobiol Dis. 2024;193:106461.
    PubMed     Abstract available
    
    
    
91. TATO-FERNANDEZ C, Ekblad LL, Pietila E, Saunavaara V, et al
    Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET.
    Neurobiol Dis. 2024;192:106439.
    PubMed     Abstract available
    
    
    
92. LONG DM, Cravetchi O, Chow ES, Allen C, et al
    The amyloid precursor protein intracellular domain induces sleep disruptions and its nuclear localization fluctuates in circadian pacemaker neurons in Drosophila and mice.
    Neurobiol Dis. 2024;192:106429.
    PubMed     Abstract available
    
    
    February 2024
93. KATSUMATA Y, Wu X, Aung KZ, Gauthreaux K, et al
    Pathologic correlates of aging-related tau astrogliopathy: ARTAG is associated with LATE-NC and cerebrovascular pathologies, but not with ADNC.
    Neurobiol Dis. 2024;191:106412.
    PubMed     Abstract available
    
    
    January 2024
94. KOURTI M, Metaxas A
    A systematic review and meta-analysis of tau phosphorylation in mouse models of familial Alzheimer's disease.
    Neurobiol Dis. 2024 Jan 31:106427. doi: 10.1016/j.nbd.2024.106427.
    PubMed     Abstract available
    
    
    
95. IVANOVA M, Belaya I, Kucharikova N, de Sousa Maciel I, et al
    Upregulation of Integrin beta-3 in astrocytes upon Alzheimer's disease progression in the 5xFAD mouse model.
    Neurobiol Dis. 2024;191:106410.
    PubMed     Abstract available
    
    
    
96. GHARPURE M, Vyavahare S, Ahluwalia P, Gupta SK, et al
    Alterations in Alzheimer's disease microglia transcriptome might be involved in bone pathophysiology.
    Neurobiol Dis. 2024;191:106404.
    PubMed     Abstract available
    
    
    
97. PIETILA E, Snellman A, Tuisku J, Helin S, et al
    Midlife insulin resistance, APOE genotype, and change in late-life brain beta-amyloid accumulation - A 5-year follow-up [(11)C]PIB-PET study.
    Neurobiol Dis. 2024;190:106385.
    PubMed     Abstract available
    
    
    December 2023
98. ZHANG T, Dolga AM, Eisel ULM, Schmidt M, et al
    Novel crosstalk mechanisms between GluA3 and Epac2 in synaptic plasticity and memory in Alzheimer's disease.
    Neurobiol Dis. 2023 Dec 22:106389. doi: 10.1016/j.nbd.2023.106389.
    PubMed     Abstract available
    
    
    
99. KOPCANOVA M, Tait L, Donoghue T, Stothart G, et al
    Resting-state EEG signatures of Alzheimer's disease are driven by periodic but not aperiodic changes.
    Neurobiol Dis. 2023 Dec 17:106380. doi: 10.1016/j.nbd.2023.106380.
    PubMed     Abstract available
    
    
    
100. LIANG K, Li X, Guo Q, Ma J, et al
     Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
     Neurobiol Dis. 2023;190:106379.
     PubMed     Abstract available
     
     
     
101. HANERT A, Schonfeld R, Weber FD, Nowak A, et al
     Reduced overnight memory consolidation and associated alterations in sleep spindles and slow oscillations in early Alzheimer's disease.
     Neurobiol Dis. 2023 Dec 14:106378. doi: 10.1016/j.nbd.2023.106378.
     PubMed     Abstract available
     
     
     
102. TIMSINA J, Ali M, Do A, Wang L, et al
     Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification.
     Neurobiol Dis. 2023;190:106373.
     PubMed     Abstract available
     
     
     November 2023
103. NAJAR J, Thorvaldsson V, Kern S, Skoog J, et al
     Polygenic risk scores for Alzheimer's disease in relation to cognitive change: A representative sample from the general population followed over 16 years.
     Neurobiol Dis. 2023;189:106357.
     PubMed     Abstract available
     
     
     
104. WOJDALA AL, Bellomo G, Gaetani L, Toja A, et al
     Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: disease staging by NF-L, p-tau181, and GFAP.
     Neurobiol Dis. 2023;189:106356.
     PubMed     Abstract available
     
     
     
105. LI K, Luo X, Zeng Q, Liu X, et al
     Gray matter structural covariance networks patterns associated with autopsy-confirmed LATE-NC compared to Alzheimer's disease pathology.
     Neurobiol Dis. 2023;189:106354.
     PubMed     Abstract available
     
     
     October 2023
106. GAUTIER MK, Kelley CM, Lee SH, Alldred MJ, et al
     Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of down syndrome and Alzheimer's disease.
     Neurobiol Dis. 2023 Oct 25:106332. doi: 10.1016/j.nbd.2023.106332.
     PubMed     Abstract available
     
     
     
107. LANOOIJ SD, Drinkenburg WHIM, Eisel ULM, van der Zee EA, et al
     The effects of social environment on AD-related pathology in hAPP-J20 mice and tau-P301L mice.
     Neurobiol Dis. 2023;187:106309.
     PubMed     Abstract available
     
     
     
108. HIGGINBOTHAM L, Carter EK, Dammer EB, Haque RU, et al
     Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairment.
     Neurobiol Dis. 2023;186:106286.
     PubMed     Abstract available
     
     
     September 2023
109. BOTELLO-MARABOTTO M, Martinez-Bisbal MC, Calero M, Bernardos A, et al
     Non-invasive biomarkers for mild cognitive impairment and Alzheimer's disease.
     Neurobiol Dis. 2023 Sep 26:106312. doi: 10.1016/j.nbd.2023.106312.
     PubMed     Abstract available
     
     
     
110. CAO E, Ma D, Nayak S, Duong TQ, et al
     Deep learning combining FDG-PET and neurocognitive data accurately predicts MCI conversion to Alzheimer's dementia 3-year post MCI diagnosis.
     Neurobiol Dis. 2023 Sep 26:106310. doi: 10.1016/j.nbd.2023.106310.
     PubMed     Abstract available
     
     
     
111. ISRAEL LL, Braubach O, Shatalova ES, Chepurna O, et al
     Exposure to environmental airborne particulate matter caused wide-ranged transcriptional changes and accelerated Alzheimer's-related pathology: A mouse study.
     Neurobiol Dis. 2023;187:106307.
     PubMed     Abstract available
     
     
     
112. MEDINA-VERA D, Zambrana-Infantes EN, Lopez-Gambero AJ, Verheul-Campos J, et al
     Transcending the amyloid-beta dominance paradigm in Alzheimer's disease: An exploration of behavioural, metabolic, and gut microbiota phenotypes in 5xFAD mice.
     Neurobiol Dis. 2023 Sep 15:106295. doi: 10.1016/j.nbd.2023.106295.
     PubMed     Abstract available
     
     
     
113. LISGARAS CP, Scharfman HE
     Interictal spikes in Alzheimer's disease: Preclinical evidence for dominance of the dentate gyrus and cholinergic control by medial septum.
     Neurobiol Dis. 2023 Sep 13:106294. doi: 10.1016/j.nbd.2023.106294.
     PubMed     Abstract available
     
     
     
114. LEITAO ADG, Ahammad RU, Spencer B, Wu C, et al
     Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce alpha-synuclein in a mouse model of Alzheimer's disease.
     Neurobiol Dis. 2023;186:106285.
     PubMed     Abstract available
     
     
     
115. SIGNAL B, Perez Suarez TG, Taberlay PC, Woodhouse A, et al
     Cellular specificity is key to deciphering epigenetic changes underlying Alzheimer's disease.
     Neurobiol Dis. 2023;186:106284.
     PubMed     Abstract available
     
     
     
116. MEEHAN CE, Schantell M, Springer SD, Wiesman AI, et al
     Movement-related beta and gamma oscillations indicate parallels and disparities between Alzheimer's disease and HIV-associated neurocognitive disorder.
     Neurobiol Dis. 2023;186:106283.
     PubMed     Abstract available
     
     
     August 2023
117. GIUFFRE GM, Quaranta D, Costantini EM, Citro S, et al
     Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia.
     Neurobiol Dis. 2023 Aug 29:106267. doi: 10.1016/j.nbd.2023.106267.
     PubMed     Abstract available
     
     
     
118. DAS M, Mao W, Voskobiynyk Y, Necula D, et al
     Alzheimer risk-increasing TREM2 variant causes aberrant cortical synapse density and promotes network hyperexcitability in mouse models.
     Neurobiol Dis. 2023 Aug 15:106263. doi: 10.1016/j.nbd.2023.106263.
     PubMed     Abstract available
     
     
     
119. ARMSTRONG MJ, Jin Y, Vattathil SM, Huang Y, et al
     Role of TET1-mediated epigenetic modulation in Alzheimer's disease.
     Neurobiol Dis. 2023;185:106257.
     PubMed     Abstract available
     
     
     
120. EMMERSON JT, Do Carmo S, Liu Y, Shalhoub A, et al
     Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model.
     Neurobiol Dis. 2023;184:106227.
     PubMed     Abstract available
     
     
     
121. DUMONT M, Agostinis A, Singh K, Swan E, et al
     Sex representation in neurodegenerative and psychiatric disorders' preclinical and clinical studies.
     Neurobiol Dis. 2023;184:106214.
     PubMed     Abstract available
     
     
     July 2023
122. TROJAN E, Curzytek K, Cieslik P, Wieronska JM, et al
     Prenatal stress aggravates age-dependent cognitive decline, insulin signaling dysfunction, and the pro-inflammatory response in the APP(NL-F/NL-F) mouse model of Alzheimer's disease.
     Neurobiol Dis. 2023 Jul 6:106219. doi: 10.1016/j.nbd.2023.106219.
     PubMed     Abstract available
     
     
     
123. LEGAZ A, Prado P, Moguilner S, Baez S, et al
     Social and non-social working memory in neurodegeneration.
     Neurobiol Dis. 2023;183:106171.
     PubMed     Abstract available
     
     
     June 2023
124. MOWRY FE, Espejo-Porras F, Shijie J, Quadri Z, et al
     Chronic nSMase inhibition suppresses neuronal exosome spreading and sex-specifically attenuates amyloid pathology in APP knock-in Alzheimer's disease mice.
     Neurobiol Dis. 2023 Jun 24:106213. doi: 10.1016/j.nbd.2023.106213.
     PubMed     Abstract available
     
     
     
125. SUN Y, Bae YE, Zhu J, Zhang Z, et al
     A splicing transcriptome-wide association study identifies novel altered splicing for Alzheimer's disease susceptibility.
     Neurobiol Dis. 2023 Jun 22:106209. doi: 10.1016/j.nbd.2023.106209.
     PubMed     Abstract available
     
     
     
126. DI MAIO A, Nuzzo T, Gilio L, Serra M, et al
     Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.
     Neurobiol Dis. 2023 Jun 17:106203. doi: 10.1016/j.nbd.2023.106203.
     PubMed     Abstract available
     
     
     
127. BRADY ES, Griffiths J, Andrianova L, Bielska MH, et al
     Alterations to parvalbumin-expressing interneuron function and associated network oscillations in the hippocampal - medial prefrontal cortex circuit during natural sleep in App(NL-G-F/NL-G-F) mice.
     Neurobiol Dis. 2023;182:106151.
     PubMed     Abstract available
     
     
     
128. FRANKLIN ZJ, Croce L, Dekeryte R, Delibegovic M, et al
     BACE cleavage of APP does not drive the diabetic phenotype of PLB4 mice.
     Neurobiol Dis. 2023;182:106142.
     PubMed     Abstract available
     
     
     
129. ZOREC R, Vardjan N
     Adrenergic regulation of astroglial aerobic glycolysis and lipid metabolism: Towards a noradrenergic hypothesis of neurodegeneration.
     Neurobiol Dis. 2023;182:106132.
     PubMed     Abstract available
     
     
     
130. LUTSHUMBA J, Wilcock D, Monson NL, Stowe AM, et al
     Sex-based differences in effector cells of the adaptive immune system during Alzheimer's disease and related dementias.
     Neurobiol Dis. 2023 Jun 15:106202. doi: 10.1016/j.nbd.2023.106202.
     PubMed     Abstract available
     
     
     
131. PATEL PJ, Ren Y, Yan Z
     Epigenomic analysis of Alzheimer's disease brains reveals diminished CTCF binding on genes involved in synaptic organization.
     Neurobiol Dis. 2023 Jun 9:106192. doi: 10.1016/j.nbd.2023.106192.
     PubMed     Abstract available
     
     
     
132. FOMINYKH V, Shadrin AA, Jaholkowski PP, Bahrami S, et al
     Shared genetic loci between Alzheimer's disease and multiple sclerosis: Crossroads between neurodegeneration and immune system.
     Neurobiol Dis. 2023 Jun 5:106174. doi: 10.1016/j.nbd.2023.106174.
     PubMed     Abstract available
     
     
     
133. DE FLORES R, Demeilliez-Servouin S, Kuhn E, Chauveau L, et al
     Respective influence of beta-amyloid and APOE epsilon4 genotype on medial temporal lobe subregions in cognitively unimpaired older adults.
     Neurobiol Dis. 2023;181:106127.
     PubMed     Abstract available
     
     
     
134. DUWAT C, Leal P, Vautheny A, Auregan G, et al
     Development of an AAV-based model of tauopathy targeting retinal ganglion cells and the mouse visual pathway to study the role of microglia in Tau pathology.
     Neurobiol Dis. 2023;181:106116.
     PubMed     Abstract available
     
     
     
135. PEDERSEN TJ, Keil SA, Han W, Wang MX, et al
     The effect of aquaporin-4 mis-localization on Abeta deposition in mice.
     Neurobiol Dis. 2023;181:106100.
     PubMed     Abstract available
     
     
     May 2023
136. SNELLMAN A, Ekblad LL, Ashton NJ, Karikari TK, et al
     Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer's disease.
     Neurobiol Dis. 2023 May 31:106175. doi: 10.1016/j.nbd.2023.106175.
     PubMed     Abstract available
     
     
     
137. MUSAEUS CS, Frederiksen KS, Andersen BB, Hogh P, et al
     Detection of subclinical epileptiform discharges in Alzheimer's disease using long-term outpatient EEG monitoring.
     Neurobiol Dis. 2023 May 15:106149. doi: 10.1016/j.nbd.2023.106149.
     PubMed     Abstract available
     
     
     
138. MABROUK R, Miettinen PO, Tanila H
     Most dystrophic neurites in the common 5xFAD Alzheimer mouse model originate from axon terminals.
     Neurobiol Dis. 2023;182:106150.
     PubMed     Abstract available
     
     
     
139. CHEN Z, Reynolds RH, Pardinas AF, Gagliano Taliun SA, et al
     The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases.
     Neurobiol Dis. 2023;180:106082.
     PubMed     Abstract available
     
     
     
140. VARBANOV H, Jia S, Kochlamazashvili G, Bhattacharya S, et al
     Rescue of synaptic and cognitive functions in polysialic acid-deficient mice and dementia models by short polysialic acid fragments.
     Neurobiol Dis. 2023;180:106079.
     PubMed     Abstract available
     
     
     April 2023
141. WITTRAHM R, Takalo M, Kuulasmaa T, Makinen PM, et al
     Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPbeta levels in cerebrospinal fluid and 2D/3D cell culture models.
     Neurobiol Dis. 2023;182:106140.
     PubMed     Abstract available
     
     
     
142. SHIN YJ, Evitts KM, Jin S, Howard C, et al
     Amyloid beta peptides (Abeta) from Alzheimer's disease neuronal secretome induce endothelial activation in a human cerebral microvessel model.
     Neurobiol Dis. 2023 Apr 14:106125. doi: 10.1016/j.nbd.2023.106125.
     PubMed     Abstract available
     
     
     
143. LI T, Li D, Wei Q, Shi M, et al
     Dissecting the neurovascular unit in physiology and Alzheimer's disease: Functions, imaging tools and genetic mouse models.
     Neurobiol Dis. 2023 Apr 4:106114. doi: 10.1016/j.nbd.2023.106114.
     PubMed     Abstract available
     
     
     
144. GRECO GA, Rock M, Amontree M, Lanfranco MF, et al
     CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement mice.
     Neurobiol Dis. 2023;179:106057.
     PubMed     Abstract available
     
     
     
145. PRADO P, Moguilner S, Mejia JA, Sainz-Ballesteros A, et al
     Source space connectomics of neurodegeneration: One-metric approach does not fit all.
     Neurobiol Dis. 2023;179:106047.
     PubMed     Abstract available
     
     
     
146. AFROZ T, Chevalier E, Audrain M, Dumayne C, et al
     Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD.
     Neurobiol Dis. 2023;179:106050.
     PubMed     Abstract available
     
     
     March 2023
147. RIZZELLO E, Pimpinella D, Pignataro A, Titta G, et al
     Lamotrigine rescues neuronal alterations and prevents seizure-induced memory decline in an Alzheimer's disease mouse model.
     Neurobiol Dis. 2023 Mar 29:106106. doi: 10.1016/j.nbd.2023.106106.
     PubMed     Abstract available
     
     
     
148. TEIPEL S, Grothe MJ
     MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology.
     Neurobiol Dis. 2023;180:106070.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum